ACI: FY26 saw modest revenue growth, margin pressure, and strategic expansion into semiconductors

About this update from Archean Chemical Industries Ltd.

FY26 revenue grew 3% YoY, but Q4 saw a 13% decline due to Industrial Salt moderation. EBITDA and PAT fell YoY, impacted by logistics costs and technical downtime in Bromine. Strategic moves include semiconductor and energy storage expansion.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Archean Chemical Industries Ltd.